Facebook Linkedin Twitter
Inside Precision Medicine CRISPR-Based Epigenome Editing Platform Identifies Genes That Improve T-Cell Therapies for Cancer Treatment

Epigenomics

CRISPR-Based Editing
News & Features

CRISPR-Based Epigenome Editing Platform Identifies Genes That Improve T-Cell Therapies for Cancer Treatment

Chris Anderson -
0
PD-1 Antibody Targeting Immune Checkpoint Inhibitor
Molecular Dx

Guardant and PICI Collaborate on Cancer Biomarker, Immunotherapy Response Study

Chris Anderson -
0
Scientific illustration of a migrating breast cancer cell - 3d illustration
Molecular Dx

GC Genome Corp. Releases Results on Liquid Biopsy Study

Malorye Branca -
0
DNA
Molecular Dx

Genetic Catalog Furthers Precision Medicine

Anita Chakraverty -
0
HPV
News & Features

The Genomic and Epigenomic Landscape of HPV in Cervical Cancer

Kathy Vuksanaj -
0
3D rendering representing interaction between brain neurons
News & Features

Mount Sinai Launches Neural Epigenomics Research Center

Chris Anderson -
0
Big genomic data visualization
News & Features

Diverse Ancestry GWAS Yields More Accurate Heart Disease Risk Scores

Anjali A. Sarkar, PhD -
0
Cancer Liquid Biopsy Developer Bluestar Raises $70M, Adds Venter to Scientific Advisory Board
Molecular Dx

Cancer Liquid Biopsy Developer Bluestar Raises $70M, Adds Venter to Scientific Advisory Board

Alex Philippidis -
0
DNA strands on unaligned genome sequence.
News & Features

MIT Researchers Publish Map of Epigenomic Markers in Non-Coding DNA

Sophia Ktori -
0
Leukaemia blood cells in CLL, SEM
Molecular Dx

Study Shows Single-Cell Analysis Can Gauge CLL Patients’ Response Rates

Inside Precision Medicine Staff Writer -
0
12Page 1 of 2

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine